China
Africa
Explore chapters and articles related to this topic
Global Health in a Digital World
Published in Rui Nunes, Healthcare as a Universal Human Right, 2022
Now, there is a consensus that the use of new communication technologies and modern information systems, such as telephone, radio, television, dedicated networks, wireless communication, and biotelemetry (used to monitor the permanence of humans in space by satellite), can bring numerous benefits to the practice of medicine and other healthcare-related professions. The concept of digital health is therefore a very broad one, encompassing the use of ICT, including mobile health (mHealth), health information technology (IT), health information systems, wearable devices, telehealth, telemedicine, machine intelligence, and augmented reality. Telephone consultations, being the most traditional form of ICT use, have some peculiarities that distinguish it from other types of telemedicine, namely the fact that it is a technology in real time and the current practice is not to store information in digital modes or audio recording.
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
Published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2020
Madeline Kelly, Arseniy Lavrov, Luis Garcia-Gancedo, Jim Parr, Robert Hart, Theresa Chiwera, Christopher E. Shaw, Ammar Al-Chalabi, Rachael Marsden, Martin R. Turner, Kevin Talbot
This exploratory study indicates that biotelemetry could help overcome some limitations of the current gold-standard measures of ALS. Comparatively, biotelemetry captures direct, objective real-life physical measurements, which are data-rich thus improving precision, and do not rely on subjective factors such as patient recall (such as ALSFRS-R) or impressions by the patient, carer or healthcare provider. Platforms incorporating multiple clinical monitoring technologies present the best opportunity to develop multiple digital biomarkers – and composite digital biomarkers combining measures across different domains that may be a more sensitive marker of disease progression than individual measures, and ultimately than the current clinical “gold standard”.